Sunshine Biopharma Inc [SBFM] stock is trading at $0.06, saw in change for the day. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SBFM shares have gain 5.52% over the last week, with a monthly amount drifted -78.36%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 15, February 2024, Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering. In a post published today on Yahoo Finance, Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the “Company”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, today announced the closing of a firm commitment underwritten public offering with gross proceeds to the Company of approximately $10.0 million, before deducting underwriting discounts and other estimated expenses payable by the Company.
From an analyst’s perspective:
Sunshine Biopharma Inc [SBFM] stock has fluctuated between $0.05 and $1.40 over the past year. Sunshine Biopharma Inc [NASDAQ: SBFM] shares were valued at $0.06 at the most recent close of the market.
Analyzing the SBFM fundamentals
Sunshine Biopharma Inc [NASDAQ:SBFM] reported sales of 20.35M for the trailing twelve months, which represents a growth of 4385.93%. Gross Profit Margin for this corporation currently stands at 0.36% with Operating Profit Margin at -0.42%, Pretax Profit Margin comes in at -1.3%, and Net Profit Margin reading is -1.32%. To continue investigating profitability, this company’s Return on Assets is posted at -0.97, Equity is -1.24 and Total Capital is -0.38. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.0523 points at the first support level, and at 0.0491 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.0603, and for the 2nd resistance point, it is at 0.0651.
Sunshine Biopharma Inc [SBFM] reported earnings per share of -$0.04 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.06/share, meaning a difference of $0.02 and a surprise factor of 33.30%.
Ratios To Look Out For
For context, Sunshine Biopharma Inc’s Current Ratio is 5.00. Further, the Quick Ratio stands at 4.11, while the Cash Ratio is 3.7. Considering the valuation of this stock, the price to sales ratio is 0.15, the price to book ratio is 0.06.
Transactions by insiders
Recent insider trading involved Slilaty Steve N., Chief Executive Officer, that happened on Feb 08 when 20000.0 shares were purchased.
